相关实验视频
Updated: Jun 15, 2025

06:31
In Vitro Culture of Epicardial Cells From Mouse Embryonic Heart
Published on: April 27, 2016
7.4K
在心力衰竭中的心上脂肪-朋友,敌人或旁观者
Aleksandra Paterek1, Marta Załęska-Kocięcka2, Zuzanna Wojdyńska2
1Department of Clinical Physiology, Centre of Postgraduate Medical Education, Warsaw, Poland.
概括
心脂肪组织 (EAT) 影响心脏功能,但其作用在心力衰竭类型之间具有矛盾的差异. 了解EAT-心肌相互作用是开发新型心力衰竭治疗的关键.
科学领域:
- 心脏病学 心脏病学
- 代谢性疾病是一种代谢性疾病.
- 心脏生理学 心脏生理学
背景情况:
- 副心脏脂肪组织 (EAT) 是一个独特的脂肪库,直接邻心肌.
- EAT在心力衰竭的病理生理学中发挥着重要作用,其中包括心力衰竭与保存的喷射分数 (HFpEF) 和心力衰竭与减少的喷射分数 (HFrEF).
研究的目的:
- 剖析EAT在心脏功能和心力衰竭中的复杂且往往具有悖论性的作用.
- 探索EAT作为心力衰竭的潜在治疗点.
主要方法:
- 审查和分析关于EAT和心脏功能的现有文献.
- 检查EAT在HFpEF与HFrEF中的差异影响.
- 研究EAT对心脏功能和心律失常的影响.
主要成果:
- 过多的EAT与健康个体心脏功能受损和HFpEF结果更差有关.
- 相反,减少EAT与更糟糕的心脏功能和HFrEF的结果有关.
- 尽管对心脏功能有潜在的有益影响,但EAT会加剧心室心律不整.
结论:
- EAT与心肌之间的相互作用是复杂的,并且取决于环境.
- 准EAT为心力衰竭提供了潜在的新型治疗策略,但需要更深入地了解其多方面的作用.
相关概念视频
Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
Imbalances in Cardiac Output
1.4K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K
Layers of the Heart Wall
2.3K
The heart wall comprises three distinct layers: the epicardium, myocardium, and endocardium. The outermost layer, the epicardium, is the visceral layer of the serous pericardium, featuring a thin, transparent mesothelial surface and an inner layer of areolar connective tissue with fat deposits that increase with age.
The myocardium, the thickest layer, consists of cardiac muscle cells interconnected by intercalated discs and crisscrossing connective tissue fibers. These muscle fibers contract...
The myocardium, the thickest layer, consists of cardiac muscle cells interconnected by intercalated discs and crisscrossing connective tissue fibers. These muscle fibers contract...
2.3K
Location and Orientation of the Heart
2.5K
The human heart, despite its modest size and weight, is an organ of remarkable strength and endurance. Roughly the size of a fist, the heart weighs between 250 and 350 grams and is nestled within the mediastinum, the medial cavity of the thorax. It extends obliquely for about 12 to 14 cm, resting on the superior surface of the diaphragm. The heart is positioned anterior to the vertebral column and posterior to the sternum, with two-thirds of its mass lying to the left of the midsternal line.
2.5K
Heart Failure Drugs: Diuretics
352
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
352
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
405
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
405

